Skip to main content
. 2017 Sep 22;8(52):89837–89847. doi: 10.18632/oncotarget.21159

Figure 4. Cellular uptake of the prepared nanoparticles in SW 480 cells.

Figure 4

(A) Quantitative analysis of the cellular uptake efficiency of different nanoparticles measured by flow cytometry. (B) Quantitative analysis of the cellular uptake efficiency of RRPHC/pDNA nanoparticles after addition of excess HA or (and) RGD peptide to saturate CD44 or (and) integrin αvβ3 receptors. *p = 0.0245 and **p = 0.0037.